Pierre DUFFAU
University Hospital, Bordeaux · University Hospital Bordeaux, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pierre DUFFAU as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04276701 · Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesUniversity Hospital, Bordeaux · active not recruiting · Systemic Lupus Erythematosus · principal investigator
- N/ANCT03841318 · Involvement of Immune Cells Derived From the Intestine in Sjogren's SyndromeUniversity Hospital, Bordeaux · completed · Sjogren's Syndrome · principal investigator
- Ph1/Ph2NCT02320357 · Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus ErythematousUniversity Hospital, Bordeaux · completed · Systemic Lupus Erythematous · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:51 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.Ann Rheum Dis · 202191 citationsRCR 6.9
- Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort.J Antimicrob Chemother · 200925 citationsRCR 0.7
- Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.Ann Intern Med · 202524 citationsRCR 8.0
- Tocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineage.J Rheumatol · 201223 citationsRCR 0.7
- Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.Expert Opin Pharmacother · 201016 citationsRCR 0.6
- Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.Thromb Res · 202416 citationsRCR 4.6
- The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study.Joint Bone Spine · 20219 citationsRCR 0.5